Literature DB >> 20439468

Direct synthesis of lamin A, bypassing prelamin a processing, causes misshapen nuclei in fibroblasts but no detectable pathology in mice.

Catherine Coffinier1, Hea-Jin Jung, Ziwei Li, Chika Nobumori, Ui Jeong Yun, Emily A Farber, Brandon S Davies, Michael M Weinstein, Shao H Yang, Jan Lammerding, Javad N Farahani, Laurent A Bentolila, Loren G Fong, Stephen G Young.   

Abstract

Lamin A, a key component of the nuclear lamina, is generated from prelamin A by four post-translational processing steps: farnesylation, endoproteolytic release of the last three amino acids of the protein, methylation of the C-terminal farnesylcysteine, and finally, endoproteolytic release of the last 15 amino acids of the protein (including the farnesylcysteine methyl ester). The last cleavage step, mediated by ZMPSTE24, releases mature lamin A. This processing scheme has been conserved through vertebrate evolution and is widely assumed to be crucial for targeting lamin A to the nuclear envelope. However, its physiologic importance has never been tested. To address this issue, we created mice with a "mature lamin A-only" allele (Lmna(LAO)), which contains a stop codon immediately after the last codon of mature lamin A. Thus, Lmna(LAO/LAO) mice synthesize mature lamin A directly, bypassing prelamin A synthesis and processing. The levels of mature lamin A in Lmna(LAO/LAO) mice were indistinguishable from those in "prelamin A-only" mice (Lmna(PLAO/PLAO)), where all of the lamin A is produced from prelamin A. Lmna(LAO/LAO) exhibited normal body weights and had no detectable disease phenotypes. A higher frequency of nuclear blebs was observed in Lmna(LAO/LAO) embryonic fibroblasts; however, the mature lamin A in the tissues of Lmna(LAO/LAO) mice was positioned normally at the nuclear rim. We conclude that prelamin A processing is dispensable in mice and that direct synthesis of mature lamin A has little if any effect on the targeting of lamin A to the nuclear rim in mouse tissues.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20439468      PMCID: PMC2898298          DOI: 10.1074/jbc.M110.128835

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Maturation of nuclear lamin A involves a specific carboxy-terminal trimming, which removes the polyisoprenylation site from the precursor; implications for the structure of the nuclear lamina.

Authors:  K Weber; U Plessmann; P Traub
Journal:  FEBS Lett       Date:  1989-11-06       Impact factor: 4.124

2.  Production of a mutation in mouse En-2 gene by homologous recombination in embryonic stem cells.

Authors:  A L Joyner; W C Skarnes; J Rossant
Journal:  Nature       Date:  1989-03-09       Impact factor: 49.962

3.  Isolation and characterization of intermediate filaments.

Authors:  P Steinert; R Zackroff; M Aynardi-Whitman; R D Goldman
Journal:  Methods Cell Biol       Date:  1982       Impact factor: 1.441

4.  An accumulation of non-farnesylated prelamin A causes cardiomyopathy but not progeria.

Authors:  Brandon S J Davies; Richard H Barnes; Yiping Tu; Shuxun Ren; Douglas A Andres; H Peter Spielmann; Jan Lammerding; Yibin Wang; Stephen G Young; Loren G Fong
Journal:  Hum Mol Genet       Date:  2010-04-26       Impact factor: 6.150

5.  Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome.

Authors:  Maria Eriksson; W Ted Brown; Leslie B Gordon; Michael W Glynn; Joel Singer; Laura Scott; Michael R Erdos; Christiane M Robbins; Tracy Y Moses; Peter Berglund; Amalia Dutra; Evgenia Pak; Sandra Durkin; Antonei B Csoka; Michael Boehnke; Thomas W Glover; Francis S Collins
Journal:  Nature       Date:  2003-04-25       Impact factor: 49.962

6.  Nuclear envelope alterations in fibroblasts from patients with muscular dystrophy, cardiomyopathy, and partial lipodystrophy carrying lamin A/C gene mutations.

Authors:  A Muchir; J Medioni; M Laluc; C Massart; T Arimura; A J van der Kooi; I Desguerre; M Mayer; X Ferrer; S Briault; M Hirano; H J Worman; A Mallet; M Wehnert; K Schwartz; G Bonne
Journal:  Muscle Nerve       Date:  2004-10       Impact factor: 3.217

7.  Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction.

Authors:  Jan Lammerding; P Christian Schulze; Tomosaburo Takahashi; Serguei Kozlov; Teresa Sullivan; Roger D Kamm; Colin L Stewart; Richard T Lee
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

8.  Some HIV protease inhibitors alter lamin A/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation.

Authors:  Martine Caron; Martine Auclair; Hélène Sterlingot; Michel Kornprobst; Jacqueline Capeau
Journal:  AIDS       Date:  2003-11-21       Impact factor: 4.177

9.  Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy.

Authors:  T Sullivan; D Escalante-Alcalde; H Bhatt; M Anver; N Bhat; K Nagashima; C L Stewart; B Burke
Journal:  J Cell Biol       Date:  1999-11-29       Impact factor: 10.539

10.  Modification of nuclear lamin proteins by a mevalonic acid derivative occurs in reticulocyte lysates and requires the cysteine residue of the C-terminal CXXM motif.

Authors:  K Vorburger; G T Kitten; E A Nigg
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more
  44 in total

1.  Structure and stability of the lamin A tail domain and HGPS mutant.

Authors:  Zhao Qin; Agnieszka Kalinowski; Kris Noel Dahl; Markus J Buehler
Journal:  J Struct Biol       Date:  2011-05-24       Impact factor: 2.867

Review 2.  Protein farnesylation and disease.

Authors:  Giuseppe Novelli; Maria Rosaria D'Apice
Journal:  J Inherit Metab Dis       Date:  2012-02-04       Impact factor: 4.982

Review 3.  Understanding the roles of nuclear A- and B-type lamins in brain development.

Authors:  Stephen G Young; Hea-Jin Jung; Catherine Coffinier; Loren G Fong
Journal:  J Biol Chem       Date:  2012-03-13       Impact factor: 5.157

4.  Regulation of prelamin A but not lamin C by miR-9, a brain-specific microRNA.

Authors:  Hea-Jin Jung; Catherine Coffinier; Youngshik Choe; Anne P Beigneux; Brandon S J Davies; Shao H Yang; Richard H Barnes; Janet Hong; Tao Sun; Samuel J Pleasure; Stephen G Young; Loren G Fong
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

5.  New Lmna knock-in mice provide a molecular mechanism for the 'segmental aging' in Hutchinson-Gilford progeria syndrome.

Authors:  Hea-Jin Jung; Yiping Tu; Shao H Yang; Angelica Tatar; Chika Nobumori; Daniel Wu; Stephen G Young; Loren G Fong
Journal:  Hum Mol Genet       Date:  2013-11-07       Impact factor: 6.150

6.  Farnesylation of lamin B1 is important for retention of nuclear chromatin during neuronal migration.

Authors:  Hea-Jin Jung; Chika Nobumori; Chris N Goulbourne; Yiping Tu; John M Lee; Angelica Tatar; Daniel Wu; Yuko Yoshinaga; Pieter J de Jong; Catherine Coffinier; Loren G Fong; Stephen G Young
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

Review 7.  Lamins and Lamin-Associated Proteins in Gastrointestinal Health and Disease.

Authors:  Graham F Brady; Raymond Kwan; Juliana Bragazzi Cunha; Jared S Elenbaas; M Bishr Omary
Journal:  Gastroenterology       Date:  2018-03-13       Impact factor: 22.682

8.  Direct Force Probe for Nuclear Mechanics.

Authors:  Vincent J Tocco; Srujana Neelam; Qiao Zhang; Richard B Dickinson; Tanmay P Lele
Journal:  Methods Mol Biol       Date:  2018

9.  Myopathic lamin mutations impair nuclear stability in cells and tissue and disrupt nucleo-cytoskeletal coupling.

Authors:  Monika Zwerger; Diana E Jaalouk; Maria L Lombardi; Philipp Isermann; Monika Mauermann; George Dialynas; Harald Herrmann; Lori L Wallrath; Jan Lammerding
Journal:  Hum Mol Genet       Date:  2013-02-19       Impact factor: 6.150

Review 10.  Nuclear lamins in the brain - new insights into function and regulation.

Authors:  Hea-Jin Jung; John M Lee; Shao H Yang; Stephen G Young; Loren G Fong
Journal:  Mol Neurobiol       Date:  2012-10-14       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.